Virginia Retirement Systems’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-61,200
Closed -$2.17M – 1364
2026
Q2
$2.17M Buy
61,200
+52,800
+629% +$1.56M 0.01% 517
2026
Q1
$233K Buy
+8,400
New +$216K ﹤0.01% 886
2025
Q3
– Sell
-76,700
Closed -$864K – 1033
2025
Q2
$864K Sell
76,700
-31,900
-29% -$346K 0.01% 609
2025
Q1
$1.1M Buy
+108,600
New +$1.17M 0.01% 539
2023
Q3
– Sell
-25,200
Closed -$254K – 1019
2023
Q2
$254K Buy
25,200
+12,200
+94% +$109K ﹤0.01% 878
2023
Q1
$95.9K Buy
+13,000
New +$107K ﹤0.01% 1005

Other funds holding ROIV

Virginia Retirement Systems's ROIV Position: Q3 2026 in Review

Virginia Retirement Systems sold out of Roivant Sciences (ROIV) in Q3 2026, closing a stake of 61,200 shares — an estimated $2.17M sold.

Virginia Retirement Systems first reported a position in ROIV in Q1 2023 and held it in 6 quarters. The position peaked at $2.17M in Q2 2026. 122 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

  • Virginia Retirement Systems reported no remaining Roivant Sciences position as of Q3 2026 after selling out during the quarter.
  • Virginia Retirement Systems sold 61,200 Roivant Sciences shares in Q3 2026, an estimated $2.17M.
  • Virginia Retirement Systems first reported a position in Roivant Sciences in Q1 2023 and held it in 6 quarters.
  • Virginia Retirement Systems's Roivant Sciences position peaked at $2.17M in Q2 2026.
  • 122 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Virginia Retirement Systems's 13F filing for Q3 2026, filed 28 Oct 2026.